Brendan Doran, PharmD

Brendan Doran, PharmD is a biotechnology executive with more than 15 years of experience leading teams in global drug development, clinical operations, and regulatory strategy. Prior to joining Clarametyx, Dr. Doran held senior leadership positions at CinRx Pharma and CTI Clinical Trials and Consulting Services. He has played key roles in strategic interactions with the U.S. Food and Drug Administration (FDA) and global regulatory bodies, guiding programs through critical stages of drug development. Dr. Doran previously practiced as a clinical pharmacist in a hospital setting and maintains an academic appointment at the University of Cincinnati James L. Winkle School of Pharmacy Division of Pharmaceutical Sciences. He earned a Bachelor of Science degree in Biology from Mercyhurst University and a Doctor of Pharmacy degree from the Lake Erie College of Osteopathic Medicine School of Pharmacy.